Inactive Instrument
Guided Therapeutics Inc Share Price OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15/07 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 16/06 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 2.65Cr 2.33Cr 2.16Cr 1.98Cr 3.74Cr 255.67Cr 3.79Cr 26Cr 10Cr 125.3Cr 9.97Cr 9.75Cr 432.64Cr | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.94Cr 2.58Cr 2.39Cr 2.2Cr 4.15Cr 283.37Cr 4.2Cr 29Cr 11Cr 138.88Cr 11Cr 11Cr 479.51Cr | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.34% | -2.12% | +29.09% | -7.02% | 20TCr | ||
| -11.39% | -10.21% | -4.97% | -30.15% | 14TCr | ||
| +1.23% | -5.88% | -30.79% | +6.10% | 13TCr | ||
| -1.43% | +1.21% | -58.43% | -18.84% | 6.51TCr | ||
| -1.45% | -7.17% | +9.23% | -9.66% | 4.89TCr | ||
| -2.38% | +0.64% | -24.65% | -32.78% | 4.49TCr | ||
| +2.15% | -1.70% | +18.61% | +4.13% | 3.68TCr | ||
| +2.21% | -3.00% | +29.62% | +26.45% | 3.51TCr | ||
| -1.30% | +1.48% | -24.98% | -10.95% | 2.86TCr | ||
| Average | -1.38% | -3.21% | -6.36% | -8.08% | 8.03TCr | |
| Weighted average by Cap. | -2.36% | -2.97% | -3.21% | -10.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7T 6.14T 5.68T 5.23T 9.87T 7L 9.99T 67.85T 26.55T 3L 26.28T 25.71T 11.41L | 8L 7L 6L 6L 10.81L 7.39Cr 10.94L 74.34L 29.09L 3.62Cr 28.79L 28.17L 12Cr |
| Net income | -24.17L -21.19L -19.63L -18.07L -34.07L -23Cr -34.48L -2.34Cr -91.68L -11Cr -90.73L -88.78L -39Cr | -31.96L -28.01L -25.96L -23.89L -45.05L -31Cr -45.59L -3.1Cr -1.21Cr -15Cr -1.2Cr -1.17Cr -52Cr |
| Net Debt | 17.71L 15.52L 14.38L 13.24L 24.96L 17Cr 25.27L 1.72Cr 67.17L 8.36Cr 66.48L 65.05L 29Cr | 28.76L 25.21L 23.36L 21.5L 40.54L 28Cr 41.03L 2.79Cr 1.09Cr 14Cr 1.08Cr 1.06Cr 47Cr |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















